← Leaderboards
Nikolai Petrovsky
Vaxine Pty Ltd
$19,015,059
Attributed
$19,015,059
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.7M · FY2014–22$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$19,015,059 · 3
By mechanism
N01$19,015,059 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesAdjuvantHuman DiseasePathogenVaccine CandidateReceptorEmerging Communicable DiseasesLeadContractorAnimal ModelIn VitroHigh Throughput ScreeningAdjuvanticityDendritic CellsInfluenzaIn VivoGenus StaphylococcusComputer SimulationInfluenzavirusJapanese Encephalitis VirusAreaFormulationAnthrax DiseaseCells
Grant awards (10)
Adjuvant Development in the context of a vaccine to protect against tuberculosis$1,551,986
N01 · FY2022 · AI · contact PI
Adjuvant Development in the context of a vaccine to protect against tuberculosis$1,170,507
N01 · FY2021 · AI · contact PI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases$3,532,876
N01 · FY2020 · AI · contact PI
Adjuvant Development in the context of a vaccine to protect against tuberculosis$1,473,199
N01 · FY2020 · AI · contact PI
Vaccine development for SARS-CoV2$500,000
N01 · FY2020 · AI · contact PI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$413,000
N01 · FY2019 · AI · contact PI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$1,904,860
N01 · FY2018 · AI · contact PI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$320,000
N01 · FY2017 · AI · contact PI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$400,000
N01 · FY2016 · AI · contact PI
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus$7,748,631
N01 · FY2014 · AI · contact PI